12:00 AM
 | 
Apr 17, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Hectorol doxercalciferol Injection regulatory update

The FDA granted marketing approval for BCII's Hectorol vitamin D prohormone injection to...

Read the full 45 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >